144 results
Page 3 of 8
8-K
EX-10.01
fo12z2 gzgoxi155
26 Jan 22
Adaptimmune Announces Appointment of Cintia Piccina as Chief Commercial Officer
8:05am
8-K
EX-10.2
e0i8rjgc
20 Aug 21
Entry into a Material Definitive Agreement
4:31pm
8-K
EX-10.1
k80xwvb71
13 Aug 21
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-10.1
uzc8k28vb3231t
16 Dec 20
Departure of Directors or Certain Officers
5:01pm
S-3ASR
ze2e2f 8z
10 Aug 20
Automatic shelf registration
5:01pm
S-3ASR
EX-1.2
7936ad3 fe78ues0m7y
10 Aug 20
Automatic shelf registration
5:01pm
S-3ASR
EX-5.1
y07yfg tma8
10 Aug 20
Automatic shelf registration
5:01pm
424B5
p49 tg8ct
2 Jun 20
Prospectus supplement for primary offering
5:05pm
8-K
EX-5.1
o4gv3 172
2 Jun 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
4:49pm
8-K
EX-1.1
cwgxi7j30h31 ow
2 Jun 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
4:49pm
424B5
98lmqu yc893y9u
1 Jun 20
Prospectus supplement for primary offering
6:06am